Theauto-injector can only be used when loaded with a syringe.
Contents of the case or cartridge
To use the auto-injector
1. Open the case or cartridge.
Remove the tamper-evident seal from one of the two syringes
that contains the cartridge.
2. Open the cap of the corresponding syringe.
3. Remove the auto-injector from the case or cartridge.
4. Insert the auto-injector firmly into the cartridge and turn the auto-injector clockwise until it cannot be turned further.
5.Push the loaded auto-injector firmly outwards. It may take a bit of effort to do so.
There is a safety button that prevents accidental injection until you are ready.
6. Press the loaded auto-injector firmly against the skin, preferably on the outer surface of the thigh or the upper outer surface of the arm (deltoid muscle), so that the gray part slides just to the blue part. To inject, press the blue button on the auto-injector and hold it firmly in place for at least five seconds (or count to ten).
7. Carefully remove the auto-injector.
Be careful as you will see the needle.
8. Immediately return the used syringe to the cartridge by pushing the auto-injector downwards into it as far as it will go. Then, turn the auto-injector counterclockwise until it comes out of the cartridge.
9. Remove the auto-injector from the cartridge; then, close the cap over the used syringe.
10. Return the auto-injector to its place in the case or cartridge by pushing it downwards. You will hear a click when the auto-injector is properly seated.
If you use more Imigran than you should:
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you have any other questions about using this medication, ask your doctor or pharmacist.
Like all medicines, Imigran can cause side effects, although not everyone will experience them. Some of these symptoms may be caused by the migraine itself.
Allergic reactions: seek medical help immediately
The following side effects have occurred in a very small number of people and their exact frequency is unknown.
If you notice any of these symptoms shortly after using Imigran:
?Do not use it again.Immediately contact your doctor.
Very common side effects
(affect more than1 in 10people)
Common side effects
(affect up to1 in 10people)
If these effects persist or worsen(especially chest pain):
?Seek urgent medical help.In a reduced number of people, these symptoms may be caused by heart attacks.
Other common side effects include:
Rare side effects
(affect up to1 in 10,000people)
Some patients may experience any of the following side effects, but the frequency with which they occur is unknown
If you have had a blood test to check how your liver is functioning and you have taken Imigran, inform your doctor, as it may affect the test results.
Reporting side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keepthis medicationout of the sight and reach of children.
Do not store at a temperature above 86°F (30°C). Store in the original packaging to protect it from light.
Do not usethis medicationafter the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at your pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medications. By doing so, you will help protect the environment.
-The active ingredient is sumatriptan. Each pre-filled syringe contains 6 milligrams of sumatriptan (as sumatriptan succinate).
-The other components are sodium chloride and water for injection.
Appearance of the product and contents of the packaging
Imigran is presented in the form of a pre-filled syringe with a solution containing 6 mg of sumatriptan. Each package contains a case or box with 2 pre-filled syringes and an auto-injector device.
The needle guard of the pre-filled syringe contains natural dry latex rubber that may cause severe allergic reactions in people sensitive to latex.
Holder of the marketing authorization and responsible manufacturer
Holder of the marketing authorization:
GlaxoSmithKline S.A.
P.T.M. C/ Severo Ochoa, 2
28760 Tres Cantos (Madrid)
Tel: +34 900 202 700
Responsible manufacturer:
GlaxoSmithKline Manufacturing S.p.A.
Strada Provinciale Asolana, 90
43056 San Polo di Torrile
Parma
Italy
Date of the last review of this leaflet:September 2020.
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.